Activity of carbapenems and tigecycline against ESBL-producing Escherichia coli and Klebsiella spp.

• Egile Nagusiak: Caio Fernando de Oliveira (Egilea), Fernando Ferrugem (Egilea), Renan V. Schmidt (Egilea), Daniel Prá (Egilea), Jorge André Horta (Egilea)
• Formatua: Liburua
• Argitaratua: Sociedade Brasileira de Patologia Clínica, 2018-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

ABSTRACT The indiscriminate use of carbapenems in the fight against multidrug resistant Gram-negative bacteria leads to the emergence of resistance to these antimicrobial agents. We examine the in vitro activity of carbapenems and tigecycline against ESBL-producing E. coli and Klebsiella spp. isolat...